News

An intraocular device is a new concept in the treatment of age-related macular degeneration that taps into telescopic mirror technology to redesign patients' vision, according to experts.

Ranibizumab for the treatment of macular edema associated with central retinal vein occlusion demonstrated rapid and sustained improvement as early as 7 days after the start of treatment through 6-month interim analysis.

Options for presbyopia-correcting lenticular surgery continue to expand.

Refractive surgeons currently using a mechanical microkeratome should consider turning their LASIK procedures into all-laser surgery by using a femtosecond laser for flap creation, according to one expert.

Now we can offer cataract patients something of added value-spectacle independence.

Instead of looking for lessons, I spend a lot of time looking for realizations.

As Congress continues to debate health-care reform and how best to pay physicians for providing medical care to the nation's neediest and elderly people, ophthalmologists are increasingly frustrated by the instability it wreaks upon their practices.

It is estimated that only 35% of those who own eyeglasses also own sunglasses.

Individuals who are visually impaired are more likely to be in a lower socioeconomic bracket in the United States, not to have private insurance, and to have an eye disease that is undetected.

As everyone knows, the key roles played by vice presidents are to go to funerals and to say things that serve as fodder for comedians.

A research team in Australia has identified a possible mechanism by which aging predisposes the eye to glaucoma.

There is no shortage of studies to measure the costs of visual impairment, but because the studies use a variety of approaches to analyze data, it has been difficult to draw conclusions.

A proprietary surgical microscope allows dynamic control of the red reflex to provide unsurpassed intraocular visualization and to improve the ease and safety of cataract surgery.

Excimer laser ablation to create a multifocal cornea is not only possible but represents a safe and effective method for treating presbyopia, according to research.

Although all practices are different, the tips outlined in this first installment of a two-part series should help to avoid the most common implementation pitfalls.

There is little debate that vision is a critical factor in sports performance.

Results from 3 and 6 months of follow-up in a U.S. clinical trial indicate that cornea collagen cross-linking is a safe treatment that decreases corneal curvature and thickness and appears to improve vision in eyes with keratoconous or ectasia after LASIK.

The term "blepharitis" encompasses a group of conditions often divided into anterior and exterior blepharitis.

An important advance for enhancing the ease and safety of pediatric cataract surgery is 1.8mm coaxial microincision cataract surgery using a particular phaco platform, according to one expert.

The public has until March 5 to submit comments related to presentations made at a Feb. 18 public hearing at which FDA officials discussed challenges related to the premarket notification, or 510(k) process, used to review and clear certain medical devices marketed in the United States.

Lux Biosciences Inc. has submitted simultaneous regulatory filings to the FDA and the European Medicines Agency seeking marketing approval for an investigational drug, oral voclosporin (LUVENIQ or LX211), for the treatment of noninfectious uveitis involving the intermediate or posterior segments of the eye.

The Japanese Ministry of Health, Labor and Welfare has given regulatory approval for STAAR Surgical Co. to market its implantable contact lens (Visian Implantable Collamer Lens) in that country for the treatment of myopia.

Odyssey Medical has introduced a punctal plug (Micro Flow) that is designed to provide a reversible means of partial occlusion by limiting the drainage of tears into the lacrimal duct.

Ophthalmic Women Leaders has appointed Pamela Gleeson, chief financial officer of Santen Inc., as its 2010 president. She previously served as chairwoman of the organization?s finance committee.

Bausch + Lomb has unveiled a redesigned company logo and icon. Both incorporate hues of the company?s traditional blue and green colors and introduce the plus symbol instead of the ampersand.

The Brehm Tower at the W.K. Kellogg Eye Center Complex, a $132 million, 230,000-square-foot, eight-story facility, opened March 1. It is adjacent to the existing Kellogg Eye Center research tower.

March 17 is the deadline for physicians to change their Medicare participation status for 2010.

The differential diagnosis for corneal infiltrate after refractive surgery includes several infectious and non-infectious etiologies.